What Researchers Did
Researchers prospectively treated 15 patients with refractory tibia osteomyelitis using adjunctive hyperbaric oxygen therapy, aggressive surgical debridement, and parenteral antibiotics.
What They Found
Successful treatment was achieved in 13 out of 15 patients (86%) with refractory tibia osteomyelitis. The average follow-up was 17.2 months, with patients receiving an average of 26 daily hyperbaric oxygen sessions over a mean treatment length of 45 days.
What This Means for Canadian Patients
Canadian patients suffering from chronic refractory tibia osteomyelitis might benefit from hyperbaric oxygen therapy as an adjunct to standard surgical and antibiotic treatments. This approach could offer a viable option for those who have not responded to conventional therapies, potentially improving treatment success rates.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
This preliminary report is limited by its small sample size of 15 patients and the lack of a precise clinical staging system for patient selection.